| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Michael S Perry is Director at ARMP and has filed Form 4s across 3 companies. From March 2015 to August 2026, the filings on record show 1 open-market purchase and 12 sales. Michael S Perry's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $11.4M at current prices.
Historically, Michael S Perry's trades have earned a middling insider score of 55/100 across 6 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +20.5%.
The biggest single holding is ARWR (~$6.6M) as Director. The ARWR filings lean toward selling, a net 257,350 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 36,000 | $35.83 | $1,289,891.00 | -81.8% | |
| Sep 11, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 185,000 | $29.41 | $5,440,000.00 | -83.7% | |
| Mar 22, 2018 | ARMP Armata Pharmaceuticals, Inc. | Director | Buy | 292,592 | $0.68 | $200,002.00 | +246.9% |